Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: Inverse regulation by cytokines and role in induction of cytotoxicity

Clinical and Experimental Immunology

Volumn 107, Issue 3, 1997, Pages 608-613

  Orengo, A M ^a,b   Cantoni, C ^a   Neglia, F ^a   Biassoni, R ^a   Ferrini, S ^a  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Activation; CD27; CD70; NK cells; T lymphocytes

Indexed keywords

CD27 ANTIGEN; CD70 ANTIGEN; INTERLEUKIN 4; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031051991     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-942.x     Document Type: Article

References (33)

1. Stein H, Gerdes J, Schwab U et al. Evidence for the detection of the normal counterpart of Hodgkin and Sternberg Reed cells. Hematol Oncol 1983; 1:21-29.
2. Stein H, Gerdes J, Schwarting R et al. Three new lymphoid activation antigens. In: McMicael AJ, Beverley PLL, Lobrolo S et al., eds. Leucocyte typing III: White cell differentiation antigens. Oxford: Oxford University Press, 1986:574-9.
3. Hintzen RQ, de Jong R, Lens SMA et al. CD27: marker and mediator of T-cell activation? Immunol Today 1994; 15:307-11.
4. Goodwill RG, Alderson MR, Smith CA et al. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 1993; 73:447-56.
5. Bowman MR, Crimmins MAV, Yetz-Aldape J et al. The cloning of CD70 and its identification as the ligand for CD27. J Immunol 1994; 152:1756-61.
6. Hintzen RQ, Lens SMA, Koopman G et al. CD70 represents the human ligand for CD27. Int Immunol 1994; 6:477-80.
7. Camerini D, Walz G, Loenen WAM et al. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J Immunol 1991; 147:3165-9.
8. van Lier RAW, Borst J, Vroom TM et al. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol 1987; 139:1589-96.
9. Bigler RD, Bushkin Y, Chiorazzi N, S152 (CD27): a modulating disulfide-linked T cell activation antigen. J Immunol 1988; 141:21-28.
10. Sugita K, Torimoto Y, Nojima Y et al. The 1A4 molecular (CD27) is involved in T cell activation. J Immunol 1991; 147:1477-83.
11. Martorell J, Rojo I. Vilella R et al. CD27 induction on thymocytes. J Immunol 1990; 145:1356-63.
12. Sugita K, Robertson MJ, Torimoto Y et al. Participation of the CD27 antigen in the regulation of IL-2-activated human NK cells. J Immunol 1992; 149:1199-203.
13. Maurer D, Holter W, Majdic O et al. CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol 1990; 20:2679-84.
14. + B lymphocyte subset. J Immunol 1992; 148:3700-5.
15. + naive T cell costimulation. J Immunol 1994; 153:5422-32.
16. Agematsu K, Kobata T, Yang FC et al. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol 1995; 25:2825-9.
17. Ferrini S, Cantoni C, Ciccone E et al. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation. Eur J Immunol 1991; 21:1981-7.
18. Cantoni C, Cambiaggi A, Sforzini S et al. Characterization of a Cyclosporin A-sensitive activation pathway in cultured T and natural killer cells. Scand J Immunol 1994; 39:373-9.
19. Morimoto C, Kobata T, van Lier RAW. Cluster report: CD70. In: Schlosman SF Bourmsell L, Gilks W et al., eds. Leucocyte typing V: White cell differentiation antigens. Oxford: Oxford University Press, 1995:1137-8.
20. - lymphocytes to express their functional program(s). J Exp Med 1988; 168:1-11.
21. Fleischer B. A novel pathway of human T cell activation via a 103 kD T cell activation antigen. J Immunol 1987; 138:1346-50.
22. Ferrini S, Biassoni R, Moretta A et al. Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid, phenotypic and functional characterization of T-cell clones capable of lysing autologous carcinoma cells. Int J Cancer 1985; 36:337-43.
23. Ranheim EA, Cantwell MJ, Kipps TJ. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 1995; 85:3556-65.
24. Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 1985; 318:665-7.
25. Scheurich P, Ucer U, Kronke M et al. Quantification and characterization of high-affinity membrane receptors for tumour necrosis factor on human leukemic cell lines. Int J Cancer 1986; 38:127-33.
26. Hintzen RQ, Lens SMA, Beckmann MP et al. Characterization of the human CD27 ligand, a novel member of the TNF gene family. J Immunol 1994; 152:1762-73.
27. Hintzen RQ, de Jong R, Lens SMA et al. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol 1993; 151:2426-35.
28. Del Prete G, Maggi E, Pizzolo G et al. CD30. Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 1995; 16:76-80.
29. Hintzen RQ, Lens SMA, Lammers K et al. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J Immunol 1995; 154:2612-23.
30. Gravestein LA, Nieland JD, Kruibeek AM et al. Novel mAbs reveal potent costimulatory activity of murine CD27. Int Immunol 1995; 7:551-7.
31. Alderson MR, Armitage RJ, Maraskovsky E et al. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 1993; 178:2231-5.
32. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995; 16:569-74.
33. Moretta A, Poggi A, Pende D et al. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing TCR α/β. J Exp Med 1991; 174:1393-8.